571 studies found for:    Open Studies | "Pulmonary Disease, Chronic Obstructive"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Resveratrol In Overweight Mild To Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)
Conditions: Pulmonary Disease, Chronic Obstructive;   Overweight
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo
2 Unknown  Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Traditional Chinese Medicine;   Drug: placebo chinese medicine
3 Unknown  Does Pulmonary Daoyin of China Give Additional Benefit Over Usual Therapy in Management of Stable Chronic Obstructive Pulmonary Disease?
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Pulmonary daoyin therapy of China;   Other: usual care
4 Not yet recruiting A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Solithromycin;   Drug: Placebo
5 Not yet recruiting Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Magnesium Sulfate;   Drug: Placebo
6 Not yet recruiting A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Rehabilitation
Intervention: Other: Pulmonary Rehabilitation
7 Recruiting A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Umeclidinium bromide;   Drug: Placebo
8 Recruiting Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/UMEC/VI;   Drug: FF/VI;   Drug: UMEC;   Drug: Placebo;   Drug: Albuterol/salbutamol
9 Recruiting A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK2269557;   Drug: Placebo;   Device: DISKUS
10 Recruiting The Nasal Airway in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: Upper airway assessment, including nasal biopsy
11 Not yet recruiting Spot Marching Exercise Test in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: 6 minute walk test (6 MWT);   Other: Spot marching test (SMT)
12 Recruiting Long-term Physical Training in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: Physical training
13 Recruiting Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: Modified Dantien Salee Yoga Training Program
14 Unknown  Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Behavioural intervention;   Behavioral: Usual care group
15 Not yet recruiting Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Spiolto
16 Recruiting Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo ELLIPTA device;   Drug: Placebo capsules for use in HANDIHALER device;   Other: Inhaler Preference Questionnaire Version 1;   Other: Inhaler Preference Questionnaire Version 2
17 Not yet recruiting Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Vahelva Respimat(Tiotropium + Olodaterol)
18 Recruiting Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: BCT197;   Drug: Placebo
19 Recruiting Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Spiolto Respimat
20 Not yet recruiting Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive (COPD)
Intervention: Other: Patient preference questionnaire

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years